CLINICAL_TRIALS ClinicalTrials.gov record update

A Non-Interventional, Observational Phase IV Study to Evaluate Safety of Rituximab (Mabthera®) in Combination With Chemotherapy in Patients Treated With CD20+ Β Chronic Lymphocytic Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01609023
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:53.390184+00:00
Published At: 2017-06-14T00:00:00+00:00
Record Updated At: 2018-06-26
Results Posted At: 2017-06-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lymphocytic Leukemia, Chronic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-26"
protocolSection.identificationModule.nctId: "NCT01609023"
protocolSection.identificationModule.officialTitle: "A Non-Interventional, Observational Phase IV Study to Evaluate Safety of Rituximab (Mabthera\u00ae) in Combination With Chemotherapy in Patients Treated With CD20+ \u0392 Chronic Lymphocytic Leukemia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-06-14"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.